Hocken A G
N Z Med J. 1979 May 23;89(636):381-2.
A reappraisal of a previous opinion, and subsequent comparative work leads to the conclusion that 40 microgram desamino arginine vasopressin (DDAVP) administered instransally, is a preferable dose to 20 microgram to use as a urinary concentrating agent in the diagnostic context, and that it is quite comparable to the standard agent, five units of pitressin tannate in oil.
在诊断过程中，经鼻给予40微克去氨基精氨酸加压素（DDAVP）作为尿液浓缩剂，比20微克的剂量更可取，并且它与标准制剂——5单位油剂鞣酸加压素相当。
